For some patients, faith plays an important part in how they cope with treatment and recovery, but whether it extends to the exam room depends on many factors.
One of three finalist essays for the 2008 CURE Extraordinary Healer Award Contest.
After a mammogram and breast cancer scare, a Broadway show provided a welcome distraction and joy, reminding me of life's beauty.
When we get cancer all the attention is focused on us, but the demands of caregiving can leave behind family and loved ones that need attention as well. Especially our children.
Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.
The phase 3 ARIEL4 trial evaluated Rubraca (rucaparib) versus chemotherapy in patients with ovarian cancer and a BRCA mutation who did not respond to two or more lines of chemotherapy.
Patients with essential thrombocythemia should know the signs and symptoms of blood clots.
Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.
Ovarian cancer, also known as “the silent killer,” may soon be detected earlier, giving women improved survival rates, with the recognition of specific early warning signs which including abdominal pain, abdominal bloating, urinary urgency or frequency, pelvic and lower back pressure, loss of appetite or feeling full quickly and abnormal vaginal bleeding.
A free online pilot program helps people with cancer and their partners work through sexual health and fertility obstacles.
In the midst of all of the things that tie us together, it’s been what many would consider the most challenging shared experience a mother and son can have – facing and surviving cancer – that has been a defining feature of our relationship and ultimately one of the most overwhelming blessings of life.
An Extraordinary Healer essay honoring TARA CHRISTION, B.S.N., RN [BONE MARROW TRANSPLANT GROUP OF GEORGIA, ATLANTA]
Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.
Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.
Grant Williams, M.D., clinical instructor and research fellow at UNC Lineberger Cancer Center, discusses the potential of using body composition to better dose cancer treatments such as chemotherapy.
An Extraordinary Healer essay honoring MASSEY NEMATOLLAHI, RN, M.SC.N., OCN, CON(C) [CLINICAL COORDINATOR, ONCOLOGY CLINICAL TRIALS, ADJUNCT CLINICAL APPOINTEE, LAWRENCE S. BLOOMBERG FACULTY OF NURSING — UNIVERSITY OF TORONTO, STRONACH REGIONAL CANCER CENTRE AT SOUTHLAKE, NEWMARKET, ONTARIO, CANADA]
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
An Extraordinary Healer essay honoring Liana (LI) Minarsky, LPN [ Eastern Connecticut Oncology and Hematology in Norwich, Connecticut ]
Sumul N. Raval, M.D., founder and director of the Zocchi Brain Tumor Center at Monmouth Medical Center and 2016 GBM hero, tells his patients, "I'm your quarterback."
"If cancer wants to come after me again, it better be ready to fight!"
"Cancer is a journey — many use that expression. Well, I do not like this 'journey,' but I adore my tour guide, Ann Puglisi, RN, OCN, an oncology nurse at Kellogg Cancer Center in Evanston, Illinois,” wrote Lori Jaffee.
Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.
Regulation changes could eliminate barriers to potentially lifesaving CAR-T cell immunotherapy for patients covered by Medicare or Medicaid.